This bill establishes a new Medicare benefit and payment system for comprehensive ALS-related services, effective in 2027, while also requiring a report on clinical trial challenges.
Janice "Jan" Schakowsky
Representative
IL-9
The ALS Better Care Act aims to improve care for individuals with ALS by establishing new Medicare coverage for essential ALS-related services starting in 2027. This includes creating a new, single payment system for providers delivering specialized care, such as therapy and nursing support. Additionally, the bill mandates a report to address current challenges in staffing and administering ALS clinical trials.
New ALS Better Care Act Proposes $800 Medicare Payment Boost to Streamline Specialized Treatment by 2027
Managing ALS is a logistical and financial marathon that usually requires a small army of specialists—from respiratory therapists to speech pathologists. Currently, the healthcare system often struggles to reimburse these multidisciplinary clinics fairly, leading to long wait times and limited access. This bill aims to fix that by adding a dedicated 'ALS-related services' benefit under Medicare Part B starting January 1, 2027. Instead of providers jumping through hoops to bill for every individual specialist, the bill creates a single, streamlined payment of $800 per visit to cover the whole team. This is a major shift designed to make sure clinics can afford to keep their doors open and their staff specialized.
Cutting the Red Tape and the Costs
One of the most significant wins for families in this bill is the 'no-cost' provision. Under Section 3, any provider who accepts this new payment must do so on an 'assignment-related' basis. In plain English, that means they can't charge you a deductible, coinsurance, or copayment for these specific ALS services. If you’re a caregiver or a patient already dealing with the high costs of durable medical equipment and home modifications, having the core medical team covered 100% by Medicare removes a massive financial headache. The bill also ensures that this $800 base rate isn't stuck in 2027; it includes an 'inflation protector'—an annual market basket increase—to make sure the payments keep up with the rising costs of medical staff and technology.
Investing in the Future of Treatment
The bill doesn't just look at current care; it’s trying to unblock the pipeline for new treatments. Section 4 requires the National Institute of Neurological Disorders and Stroke to cough up a report within 90 days identifying why ALS clinical trials are so hard to staff and run. For a patient in a rural area or a younger professional diagnosed with the disease, this could eventually mean more local access to cutting-edge trials and telehealth options. The bill even allows for payment 'bonuses' for clinics that participate in clinical trials, recognizing that the extra paperwork and monitoring shouldn't be a financial burden on the facility.
The Fine Print on 'Qualified' Care
While the bill is a huge step forward, there is some 'wait and see' involved regarding who actually gets to provide this care. The Secretary of Health and Human Services is tasked with writing the rules for what makes a clinic a 'qualified provider.' If these rules are too strict, smaller local clinics might be left out; if they’re too loose, the quality of that 'multidisciplinary' care might vary. However, the bill does require the government to consult with actual ALS patients and organizations before setting these rules. For anyone navigating this diagnosis, this bill represents a move toward treating the disease as the complex, team-based challenge it really is, rather than a series of disconnected doctor appointments.